Covid-19: Big pharma to the rescue

Dec 02, 2020
As the world watches and waits for a vaccine, we ask what IR is like under the pandemic spotlight
‘The scrutiny is extraordinarily high,’ says Nick Mazing, director of research at Sentieo, talking about the media and market focus on pharmaceuticals and biotech firms involved in the fight against Covid-19. ‘And it’s not just scrutiny. It is interference.’ As

Content Preview

to continue reading

Sign up to get stories direct to your inbox
logo-black logo-black